Analysis of SETD7 expression in a second large cohort of AD patients from the Mayo clinic [30] showed a slightly increased expression in patients with higher Braak stages (Braak V-VI vs. 0-II: FC 1.33 and FDR 0.0002, Braak V-VI vs. III-IV: FC 1.2 and FDR 0.032), as well as a difference between AD and control samples (FC 1.23 and FDR 0.015, Suppl. The gene discussed is SETD7; the disease is Alzheimer disease.